These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24130398)

  • 1. Bedaquiline: a new drug approved for treatment of multidrug-resistant tuberculosis.
    Deoghare S
    Indian J Pharmacol; 2013; 45(5):536-7. PubMed ID: 24130398
    [No Abstract]   [Full Text] [Related]  

  • 2. Bedaquiline: a novel antitubercular drug for multidrug-resistant tuberculosis.
    Nagabushan H; Roopadevi HS
    J Postgrad Med; 2014; 60(3):300-2. PubMed ID: 25121373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bedaquiline: a novel antitubercular agent for the treatment of multidrug-resistant tuberculosis.
    Worley MV; Estrada SJ
    Pharmacotherapy; 2014 Nov; 34(11):1187-97. PubMed ID: 25203970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis.
    Chahine EB; Karaoui LR; Mansour H
    Ann Pharmacother; 2014 Jan; 48(1):107-15. PubMed ID: 24259600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA approval of bedaquiline--the benefit-risk balance for drug-resistant tuberculosis.
    Cox E; Laessig K
    N Engl J Med; 2014 Aug; 371(8):689-91. PubMed ID: 25140952
    [No Abstract]   [Full Text] [Related]  

  • 6. BPaL approved for multidrug-resistant tuberculosis.
    Burki T
    Lancet Infect Dis; 2019 Oct; 19(10):1063-1064. PubMed ID: 31559963
    [No Abstract]   [Full Text] [Related]  

  • 7. Multidrug-resistant tuberculosis and bedaquiline.
    Salfinger M; Somoskövi A
    N Engl J Med; 2014 Dec; 371(25):2435-6. PubMed ID: 25517715
    [No Abstract]   [Full Text] [Related]  

  • 8. Multidrug-resistant tuberculosis and bedaquiline.
    Diacon AH; Lounis N; Dannemann B
    N Engl J Med; 2014 Dec; 371(25):2436. PubMed ID: 25517714
    [No Abstract]   [Full Text] [Related]  

  • 9. Initial experience of bedaquiline use in a series of drug-resistant tuberculosis patients from India.
    Udwadia ZF; Amale RA; Mullerpattan JB
    Int J Tuberc Lung Dis; 2014 Nov; 18(11):1315-8. PubMed ID: 25299863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bedaquiline: Introducing a new drug to the MDR TB armamentarium.
    Kambili C
    Indian J Tuberc; 2016 Jul; 63(3):137-138. PubMed ID: 27865232
    [No Abstract]   [Full Text] [Related]  

  • 11. Multidrug-resistant tuberculosis and beyond: an updated analysis of the current evidence on bedaquiline.
    Pontali E; D'Ambrosio L; Centis R; Sotgiu G; Migliori GB
    Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28331046
    [No Abstract]   [Full Text] [Related]  

  • 12. Combating drug-resistant tuberculosis: the unexpected benefits of bedaquiline.
    Furin J; Diacon AH; Andries K
    Int J Tuberc Lung Dis; 2017 Jan; 21(1):4-5. PubMed ID: 28157457
    [No Abstract]   [Full Text] [Related]  

  • 13. Bedaquiline in multidrug-resistant pulmonary tuberculosis GENESIS-SEFH drug evaluation report.
    Borrego Izquierdo Y; López Briz E; Márquez Saavedra E
    Farm Hosp; 2015 Jan; 39(1):1-5. PubMed ID: 25680429
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of bedaquiline to treat patients with multidrug-resistant tuberculosis and end-stage renal disease: A case report.
    Park S; Lee KM; Kim I; Mok J
    Int J Infect Dis; 2018 Nov; 76():88-90. PubMed ID: 30244076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of tuberculosis: Focus on bedaquiline.
    Chan B; Khadem TM; Brown J
    Am J Health Syst Pharm; 2013 Nov; 70(22):1984-94. PubMed ID: 24173008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
    Guglielmetti L; Le Dû D; Veziris N; Caumes E; Marigot-Outtandy D; Yazdanpanah Y; Robert J; Fréchet-Jachym M;
    Eur Respir J; 2016 Aug; 48(2):582-5. PubMed ID: 27338196
    [No Abstract]   [Full Text] [Related]  

  • 17. Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
    Achar J; Hewison C; Cavalheiro AP; Skrahina A; Cajazeiro J; Nargiza P; Herboczek K; Rajabov AS; Hughes J; Ferlazzo G; Seddon JA; du Cros P
    Emerg Infect Dis; 2017 Oct; 23(10):1711-3. PubMed ID: 28758889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedaquiline or delamanid for rifampin-resistant tuberculosis?
    Lessem E; Cox V; Furin J
    Lancet Respir Med; 2017 Oct; 5(10):772-774. PubMed ID: 28887015
    [No Abstract]   [Full Text] [Related]  

  • 19. Current issues with the use of bedaquiline.
    Kakkar AK; Dahiya N
    Ann Pharmacother; 2014 May; 48(5):666. PubMed ID: 24519480
    [No Abstract]   [Full Text] [Related]  

  • 20. Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon.
    Andres S; Merker M; Heyckendorf J; Kalsdorf B; Rumetshofer R; Indra A; Hofmann-Thiel S; Hoffmann H; Lange C; Niemann S; Maurer FP
    Am J Respir Crit Care Med; 2020 Jun; 201(12):1564-1568. PubMed ID: 32053752
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.